HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

PD-184161

HCID 9937619
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
212631-67-9
Standard SMILES
O=C(NOCC1CC1)c1cc(Br)c(F)c(F)c1Nc1ccc(I)cc1Cl
InChIKey
VJNZMSLGVUSPCF-UHFFFAOYSA-N
Molecular formula
C17H13BrClF2IN2O2
Average molar mass
557.6 g/mol
Monoisotopic mass
555.88617

Names & identifiers

Preferred name
PD-184161
IUPAC
5-bromo-2-(2-chloro-4-iodoanilino)-N-(cyclopropylmethoxy)-3,4-difluorobenzamide
English name
PD 184161
Molecular formula
C17H13BrClF2IN2O2
Molecular weight
557.56

Names & synonyms

PD-1841615-Bromo-2-((2-chloro-4-iodophenyl)amino)-N-(cyclopropylmethoxy)-3,4-difluorobenzamide5-Bromo-2-[(2-chloro-4-iodophenyl)amino]-N-(cyclopropylmethoxy)-3,4-difluorobenzamideRefChem:858795663-378-1212631-67-9PD184161PD 1841612-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluoro-5-bromobenzamide5-bromo-2-(2-chloro-4-iodoanilino)-N-(cyclopropylmethoxy)-3,4-difluorobenzamideHMS3263A07MFCD16038897
Show more names
UK-287074PF-3011370PF-1529483MEK1/2 Inhibitor IVMEK1/2 Inhibitor IV - CAS 212631-67-9 - CalbiochemBenzamide, 5-bromo-2-[(2-chloro-4-iodophenyl)amino]-N-(cyclopropylmethoxy)-3,4-difluoro-MAP2K,PD-184161,cell,Apoptosis,neurons,Mitogen-activated protein kinase kinase,stroke,PD184161,depressive,PD 184161,cancer,HCC,MAPKK,Inhibitor,inhibit,MEK,behavioral
C17H13BrClF2IN2O2orb1306264SCHEMBL2722332SCHEMBL29376205DTXSID50433041GLXC-07277Tox21_500963AKOS030241777

Database identifiers

CAS
212631-67-9
PubChem CID
9937619
DTXSID
DTXSID50433041
EC Number
663-378-1

Properties

Computed structural propertiesFilling in

XLogP
6.3
Topological polar surface area
50.4 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
5
Rotatable bonds
6
Heavy atoms
26
Formal charge
0
Complexity
505

Physicochemical properties

Melting point
174 · 174-175 °C
Density
1.922 · 1.922±0.06 g/cm3(Predicted)
storage temp.
2 · 2-8°C
solubility
10 mg/mL · DMSO: >10mg/mL
form
White solid
pka
-6.25 · -6.25±0.50(Predicted)
color
white to off-white
InChI
1S/C17H13BrClF2IN2O2/c18-11-6-10(17(25)24-26-7-8-1-2-8)16(15(21)14(11)20)23-13-4-3-9(22)5-12(13)19/h3-6,8,23H,1-2,7H2,(H,24,25)
InChIKey
VJNZMSLGVUSPCF-UHFFFAOYSA-N
SMILES
Ic1cc(c(cc1)Nc2c(c(c(cc2C(=O)NOCC3CC3)Br)F)F)Cl
UNSPSC Code
12352200 · 12352200
NACRES
77 · NA.77
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
315 · H315-H319

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Warning

H400 (100%): Very toxic to aquatic life [Warning Hazardous to the aquatic environment, acute hazard]

P273, P391, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 38 reports by companies from 1 notifications to the ECHA C&L Inventory.

Hazard information

Hazard Classes and CategoriesAquatic Acute 1 (100%)

Safety data

wgk
3
Signal word
Warning
Symbol(GHS)
GHS07
Storage Class
11 - Combustible Solids
Hazard statements
H315-H319
Precautionary statements
P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313

Chemistry & industry

Applications · 2 items

UsesA novel mitogen-activated protein kinase kinase (MEK) inhibitor shown to exhibit antitumor effects and suppress MEK-extracellular signal-related kinase signaling activity and cell proliferation in human hepatocellular carcinoma cells and in human hepatocellular carcinoma xenografts.

General DescriptionA cell-permeable, blood-brain barrier permeant, and orally active hydroxamate compound that is reported to inhibit MEK activity (IC50 = 10-100 nM) without competing against ATP or Erk binding and exhibit excellent selectivity over 27 other cellular kinases, including JNK, MAPK2/ERK2, SAPK2a, SAPK2b, SAPK3, and SAPK4 (IC50 >10 M). Shown to be superior to PD 98059 and U0126 in suppressing Erk1/2 phosphorylation in Hep3B, HepG2, PLC, and SKHep human liver cancer cells (IC50<0.1 M) in vitro and effectively reduce Erk1/2 phosphorylation in hippocampal tissue in mice (ED50<50 mg/kg, i.p.) in vivo. Both PD184161 and U0126 are shown to induce necrosis of several types of glucose-deprived cells via an indirect action on the F0 component of the mitochondrial F1F0-ATPase/synthase.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Precautionary statements
264 · P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313
WGK Germany
3 · 3
Storage Class
11 · 11 - Combustible Solids